Northstar Healthcare Sivem Pharmaceuticals Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Northstar Healthcare Sivem Pharmaceuticals Pharmaceutical Import Records from India — 2 Products, $300.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Northstar Healthcare Sivem Pharmaceuticals — Pharmaceutical Importer Profile (2026) | 2 Products, $300.0K Trade | TransData Nexus

Northstar Healthcare Sivem Pharmaceuticals

Pharmaceutical Importer · United States · Antivirals Focus · $300.0K Total Trade · DGFT Verified

Northstar Healthcare Sivem Pharmaceuticals is a pharmaceutical importer based in United States with a total trade value of $300.0K across 2 products in 1 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Northstar Healthcare Sivem Pharmaceuticals sources from 1 verified Indian supplier, with Aurobindo Pharma Limited accounting for 100.0% of imports.

Northstar Healthcare Sivem Pharmaceuticals — Import Portfolio & Supplier Network

Northstar Healthcare Sivem Pharmaceuticals import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Northstar Healthcare Sivem Pharmaceuticals?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Limited	$915.0K	26	100.0%

Northstar Healthcare Sivem Pharmaceuticals sources from 1 verified Indian supplier across 21 distinct formulations. The sourcing is highly concentrated — Aurobindo Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Valaciclovir tablets 500MG valacyclovirtablets 500 MG	$150.0K	3
Escitalopram 10 MG tablets escitalopram10mg	$150.0K	3
Gabapentin capsules 400MG gabapentin capsules 400 MG	$50.0K	1
Gabapentin capsules 100MG gabapentin capsules 100 MG	$50.0K	1
Levetiracetam tablets 500MG levetiracetam 500	$50.0K	1
Gabapentin capsules 300MG gabapentin capsules	$50.0K	1
Gabapentin capsules 300MG gabapentin capsules	$50.0K	1
Gabapentin capsules 100MG gabapentin capsules	$50.0K	1
Escitalopram 20 MG tablets escitalopram20mg	$50.0K	1
Levetiracetam tablets 750MG levetiracetam 750	$45.3K	1
Gabapentin capsules 100MG gabapentin capsules	$35.9K	1
Mirtazapine tablets 15MG mirtazapine 15MG 17568x100's	$32.4K	1
Mirtazapine tablets 30MG mirtazapine 30MG 10224 x 100's	$31.7K	1
Gabapentin capsules 100MG gabapentin capsules 100 MG	$30.9K	1
Cyclobenzaprine hydrochloride tablets 10MG cyclobenzaprine 10MG	$23.1K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Acyclovir	Antivirals	$150.0K	3	0.1%	15
2	Valacyclovir	Antivirals	$150.0K	3	0.2%	11

Northstar Healthcare Sivem Pharmaceuticals imports 2 pharmaceutical products across 1 categories into United States totaling $300.0K.

Northstar Healthcare Sivem Pharmaceuticals — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Northstar Healthcare Sivem Pharmaceuticals is a pharmaceutical importer and buyer based in the United States, specializing in the acquisition of finished pharmaceutical formulations from India. The company operates as a key player in the U.S. pharmaceutical distribution network, focusing on sourcing generic medications to meet domestic demand. While specific details about its headquarters and parent company are not publicly disclosed, the company's operations are integral to the U.S. healthcare supply chain, ensuring the availability of essential generic drugs.

2Distribution Network

The distribution network of Northstar Healthcare Sivem Pharmaceuticals is strategically designed to facilitate efficient logistics and timely delivery of pharmaceutical products. Although specific warehouse locations and logistics capabilities are not publicly detailed, the company's import activities indicate a well-established infrastructure capable of handling international shipments. The geographic coverage primarily spans the United States, with a focus on ensuring nationwide distribution of imported pharmaceutical products.

3Industry Role

In the U.S. pharmaceutical supply chain, Northstar Healthcare Sivem Pharmaceuticals functions as a pharmaceutical importer and buyer. By sourcing finished pharmaceutical formulations from Indian manufacturers, the company plays a crucial role in enhancing the availability of generic medications within the U.S. market. This position supports the broader healthcare system by providing cost-effective alternatives to brand-name drugs, thereby contributing to the affordability and accessibility of healthcare for patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Northstar Healthcare Sivem Pharmaceuticals

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Northstar Healthcare Sivem Pharmaceuticals demonstrates a high degree of supplier concentration, with all its imports originating from a single supplier, Aurobindo Pharma Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments—26 in total—suggests a stable and reliable relationship between the importer and the supplier. The focus on two products, Acyclovir and Valacyclovir, indicates a strategic choice to concentrate on high-demand antiviral medications, potentially leveraging favorable pricing and supply terms with Aurobindo Pharma Limited.

2Supply Chain Resilience

The resilience of Northstar Healthcare Sivem Pharmaceuticals's supply chain is closely tied to its exclusive reliance on Aurobindo Pharma Limited for sourcing finished pharmaceutical formulations. This singular sourcing strategy may limit the company's ability to mitigate risks associated with supply chain disruptions. The lack of publicly available information regarding backup suppliers and the diversity of formulations imported suggests a need for strategic diversification to enhance supply chain robustness. Additionally, the company's exposure to specific shipping routes and its compliance with regulatory standards are not detailed, highlighting areas for potential improvement in supply chain resilience.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which sets forth requirements for drug safety, efficacy, and quality. The FDA's Center for Drug Evaluation and Research (CDER) is responsible for evaluating and approving new drugs, including generics, ensuring they meet the necessary standards before entering the U.S. market. For Indian generics, the FDA's Abbreviated New Drug Application (ANDA) pathway allows for the approval of generic drugs based on the demonstration of bioequivalence to the reference listed drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent, necessitating that foreign manufacturers obtain FDA approval for their products. This includes compliance with Good Manufacturing Practice (GMP) standards, which ensure that drugs are produced consistently and controlled to quality standards. The FDA recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), facilitating the acceptance of foreign-produced drugs. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the U.S., ensuring that all intermediaries in the supply chain adhere to regulatory standards.

Northstar Healthcare Sivem Pharmaceuticals — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Northstar Healthcare Sivem Pharmaceuticals's product strategy focuses on importing antiviral medications, specifically Acyclovir and Valacyclovir, which are essential in the treatment of herpes simplex and varicella-zoster viruses. The market demand for these drugs is driven by the prevalence of viral infections and the need for effective antiviral therapies. By concentrating on these specific therapeutic areas, the company aims to meet a critical healthcare need while optimizing its supply chain and operational efficiencies.

2Sourcing Profile

The company's sourcing strategy is centered on generic drugs, with a particular emphasis on antiviral formulations. India's robust pharmaceutical manufacturing sector, characterized by its compliance with international GMP standards and cost-effective production capabilities, aligns well with Northstar Healthcare Sivem Pharmaceuticals's procurement needs. This strategic sourcing approach enables the company to provide affordable and reliable antiviral medications to the U.S. market.

3Market Positioning

Based on its product mix, Northstar Healthcare Sivem Pharmaceuticals serves the wholesale distribution segment of the U.S. pharmaceutical market. By importing generic antiviral medications, the company supplies these products to various stakeholders, including retail pharmacies, hospitals, and healthcare providers, thereby contributing to the overall healthcare infrastructure and patient care.

Seller's Guide — How to Become a Supplier to Northstar Healthcare Sivem Pharmaceuticals

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Northstar Healthcare Sivem Pharmaceuticals by offering a broader range of generic antiviral products or by providing alternative sources for existing products. Gaps in the company's current sourcing include a limited product portfolio and reliance on a single supplier, which presents an opportunity for diversification and risk mitigation. Indian exporters can capitalize on these gaps by ensuring compliance with FDA regulations, maintaining high-quality manufacturing standards, and establishing reliable supply chains to meet the importer's needs.

2Requirements & Qualifications

Indian exporters seeking to supply Northstar Healthcare Sivem Pharmaceuticals and the U.S. market must obtain FDA approval for their products, demonstrating compliance with GMP standards recognized by the FDA, WHO, or PIC/S. Additionally, they must ensure that their products meet FDA labeling requirements, including the use of English language and the inclusion of specific information such as dosage instructions, active ingredients, and storage conditions. Serialization mandates must also be adhered to, facilitating the tracking and tracing of pharmaceutical products within the supply chain.

Frequently Asked Questions — Northstar Healthcare Sivem Pharmaceuticals

What products does Northstar Healthcare Sivem Pharmaceuticals import from India?

Northstar Healthcare Sivem Pharmaceuticals imports 2 pharmaceutical products across 1 categories. Top imports: Acyclovir ($150.0K), Valacyclovir ($150.0K).

Who supplies pharmaceuticals to Northstar Healthcare Sivem Pharmaceuticals from India?

Northstar Healthcare Sivem Pharmaceuticals sources from 1 verified Indian suppliers. The primary supplier is Aurobindo Pharma Limited (100.0% of imports, $915.0K).

What is Northstar Healthcare Sivem Pharmaceuticals's total pharmaceutical import value?

Northstar Healthcare Sivem Pharmaceuticals's total pharmaceutical import value from India is $300.0K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Northstar Healthcare Sivem Pharmaceuticals focus on?

Northstar Healthcare Sivem Pharmaceuticals imports across 1 categories. The largest: Antivirals (100.0%).

Get Full Northstar Healthcare Sivem Pharmaceuticals Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Northstar Healthcare Sivem Pharmaceuticals

Northstar Healthcare Sivem Pharmaceuticals — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Northstar Healthcare Sivem Pharmaceuticals?

What Formulations Does Northstar Healthcare Sivem Pharmaceuticals Import?

What Products Does Northstar Healthcare Sivem Pharmaceuticals Import?

Top Products by Import Value

Northstar Healthcare Sivem Pharmaceuticals Therapeutic Categories — 1 Specializations